anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Paragraph

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 118,471
Current window 95,101-95,130
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all
18 30 60

Component

95,101-95,130 of 118,471

filter-aware
104
Lemonade | Investor Day Presentation Deck | 125 slidesLemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations 1 hit
115
Lemonade | Investor Day Presentation Deck | 125 slidesLemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations Beat · Action1 hit
121
Lemonade | Investor Day Presentation Deck | 125 slidesLemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations Beat · Action1 hit
125
Lemonade | Investor Day Presentation Deck | 125 slidesLemonade | Investor Day Presentation Deck | 125 slides · Lemonade
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Matson | Investor Presentation Deck | 15 slidesMatson | Investor Presentation Deck | 15 slides · Matson
Conference presentation Investor relations 1 hit
10
The chart shows a significant increase in equity income for LTM 3Q22.Matson | Investor Presentation Deck | 15 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
15
Includes detailed footnotes explaining tax adjustments and calculation methodologies.Matson | Investor Presentation Deck | 15 slides · Matson
Conference presentation Investor relations 1 hit
01
Slide 1
Matson | Results Presentation Deck | 20 slidesMatson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations Beat · Attention1 hit
13
The chart shows a starting cash flow of $1,503.3M and a final net increase in cash of $165.5M after various outflows.Matson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Pareto Focus1 hit
20
Includes two separate tables for different time periods.Matson | Results Presentation Deck | 20 slides · Matson
Conference presentation Investor relations 1 hit
11
The slide uses a standard waterfall chart to bridge revenue components.Membership Collective Group | Results Presentation Deck | 29 slides · Membership Collective Group
Deck Investor relations Beat · What Could Be1 hit
16
Membership Collective Group | Results Presentation Deck | 29 slidesMembership Collective Group | Results Presentation Deck | 29 slides · Membership Collective Group
Deck Investor relations Beat · What Could Be1 hit
21
Membership Collective Group | Results Presentation Deck | 29 slidesMembership Collective Group | Results Presentation Deck | 29 slides · Membership Collective Group
Deck Investor relations Beat · What Could Be1 hit
28
Contains three distinct financial reconciliation tables for the 13 weeks ending Oct 2, 2022 and Oct 3, 2021.Membership Collective Group | Results Presentation Deck | 29 slides · Membership Collective Group
Deck Investor relations Beat · What Could Be1 hit
29
The table shows debt components, cash, and restricted cash to arrive at Net Debt, including percentage changes in actuals and constant currency.Membership Collective Group | Results Presentation Deck | 29 slides · Membership Collective Group
Deck Investor relations Beat · What Could Be1 hit
01
Slide 1
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
03
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
06
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
20
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Proposed SolutionLoop · Logic Chain1 hit
26
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
29
The slide uses a process flow diagram to show trial progression and a list-based structure for clinical endpoints.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
33
The slide uses a staircase diagram to represent dose escalation levels.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
40
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Key Takeaways1 hit
43
The slide uses a biological process diagram to explain the mechanism of action of the CARDIS platform.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
53
The slide uses a circular flow diagram to suggest a cycle of improvement or replacement of existing therapies.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
61
The slide outlines a three-stage process: Cell expansion, Harvest & Purification, and Formulating & Fill/Finish.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
62
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
63
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
65
The diagram illustrates the biological mechanism of iNKT cells interacting with other immune cells (DC, MDSC, Inflammatory Monocyte) to control secondary bacterial pneumonia and inflammation.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
70
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit